Manus

📍 Boston, United States🗓 Founded 2011👥 177 employees💰 Last funded Nov 2024
Biotechnology Research🌐 manus.bio
Website LinkedIn
Manus is the world’s leading bioalternatives scale-up platform. We work with companies across industries and value chains to accelerate the transition to bioalternatives – better performing and more sustainable versions of complex molecules traditionally sourced from plants, animals, or fossil fuels. Our platform is proven to work across scales, bridging the Valley of Death between lab and manufacturing more efficiently and more reliably to deliver the benefits of biomanufacturing, today.
5
Total investors
0
Early stage
0
Mid stage
3
Late stage
2011
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
2
Spain
1
United Kingdom
1
Investor activity2017–2024 · investors recorded per year
2017320242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Manus?
Manus has 5 investors on record on gritt.io and 3 late-stage investors.
When did Manus last raise funding?
The most recent investment in Manus recorded on gritt.io was in November 2024.
When was Manus founded?
Manus was founded in 2011.
What industry is Manus in?
Manus operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Manus based?
Manus is headquartered in Boston, United States.